A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

XenoPort, Inc.

ClinicalTrials.gov Identifier:

NCT01171313

First received: July 26, 2010

Last updated: February 4, 2013

Last verified: February 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2011
Primary Completion Date:	October 2011 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	January 31, 2013